Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets

被引:52
|
作者
Harish, Vancha [1 ]
Haque, Effi [2 ]
Smiech, Magdalena [2 ]
Taniguchi, Hiroaki [2 ]
Jamieson, Sarah [3 ]
Tewari, Devesh [4 ]
Bishayee, Anupam [3 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Phagwara 144411, Punjab, India
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Embryol, PL-05552 Jastrzebiec, Poland
[3] Lake Erie Coll Osteopath Med, Bradenton, FL 34211 USA
[4] Lovely Profess Univ, Sch Pharmaceut Sci, Dept Pharmacognosy, Phagwara 144411, Punjab, India
关键词
xanthohumol; Humulus lupulus L; cancer; proliferation; apoptosis; therapy; prevention; molecular targets; HOPS HUMULUS-LUPULUS; CELL-CYCLE ARREST; B INHIBITOR XANTHOHUMOL; NOTCH SIGNALING PATHWAY; HEPATIC STELLATE CELLS; FACTOR-KAPPA-B; PRENYLATED CHALCONE; CANCER-CELLS; IN-VIVO; APOPTOSIS;
D O I
10.3390/ijms22094478
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Xanthohumol (XH) is an important prenylated flavonoid that is found within the inflorescence of Humulus lupulus L. (Hop plant). XH is an important ingredient in beer and is considered a significant bioactive agent due to its diverse medicinal applications, which include anti-inflammatory, antimicrobial, antioxidant, immunomodulatory, antiviral, antifungal, antigenotoxic, antiangiogenic, and antimalarial effects as well as strong anticancer activity towards various types of cancer cells. XH acts as a wide ranging chemopreventive and anticancer agent, and its isomer, 8-prenylnaringenin, is a phytoestrogen with strong estrogenic activity. The present review focuses on the bioactivity of XH on various types of cancers and its pharmacokinetics. In this paper, we first highlight, in brief, the history and use of hops and then the chemistry and structure-activity relationship of XH. Lastly, we focus on its prominent effects and mechanisms of action on various cancers and its possible use in cancer prevention and treatment. Considering the limited number of available reviews on this subject, our goal is to provide a complete and detailed understanding of the anticancer effects of XH against different cancers.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment
    Li, Dongning
    Zhang, Jie
    Zhao, Xiaoyan
    CANCER INVESTIGATION, 2021, 39 (08) : 675 - 684
  • [32] Bioavailability and Cardiometabolic Effects of Xanthohumol: Evidence from Animal and Human Studies
    Neumann, Hannah F.
    Frank, Jan
    Venturelli, Sascha
    Egert, Sarah
    MOLECULAR NUTRITION & FOOD RESEARCH, 2022, 66 (06)
  • [33] Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis
    Aggarwal, Bharat B.
    Van Kuiken, Michelle E.
    Iyer, Laxmi H.
    Harikumar, Kuzhuvelil B.
    Sung, Bokyung
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 234 (08) : 825 - 849
  • [34] Exploring the molecular targets of dietary flavonoid fisetin in cancer
    Syed, Deeba N.
    Adhami, Vagar Mustafa
    Khan, Naghma
    Khan, Mohammad Imran
    Mukhtar, Hasan
    SEMINARS IN CANCER BIOLOGY, 2016, 40-41 : 130 - 140
  • [35] Molecular targets and pharmacokinetics of cucumarioside A2-2
    Pislyagin, E. A.
    Dmitrenok, P. S.
    Gladkikh, R. V.
    Gorpenchenko, T. Y.
    Aminin, D. L.
    FEBS JOURNAL, 2014, 281 : 585 - 585
  • [36] Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice
    Vene, Roberta
    Benelli, Roberto
    Minghelli, Simona
    Astigiano, Simonetta
    Tosetti, Francesca
    Ferrari, Nicoletta
    MOLECULAR MEDICINE, 2012, 18 (09) : 1292 - 1302
  • [37] Antioxidant Potential of Xanthohumol in Disease Prevention: Evidence from Human and Animal Studies
    Piekara, Jakub
    Piasecka-Kwiatkowska, Dorota
    ANTIOXIDANTS, 2024, 13 (12)
  • [38] Pharmacokinetics of xanthohumol in rats of both sexes after oral and intravenous administration of pure xanthohumol and prenylflavonoid extract
    Nowak, Beata
    Pozniak, Blazej
    Poplonski, Jaroslaw
    Bobak, Lukasz
    Matuszewska, Agnieszka
    Kwiatkowska, Joanna
    Dziewiszek, Wojciech
    Huszcza, Ewa
    Szelag, Adam
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (09): : 1101 - 1109
  • [39] IAPs as therapeutic targets in haematological malignancies
    Langemeijer, S. M. C.
    de Graaf, A. O.
    Jansen, J. H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (08) : 981 - 993
  • [40] Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
    Sari, Anissa Nofita
    Bhargava, Priyanshu
    Dhanjal, Jaspreet Kaur
    Putri, Jayarani F.
    Radhakrishnan, Navaneethan
    Shefrin, Seyad
    Ishida, Yoshiyuki
    Terao, Keiji
    Sundar, Durai
    Kaul, Sunil C.
    Wadhwa, Renu
    CANCERS, 2020, 12 (05)